Key indicators: single-crystal X-ray study; T = 200 K; mean (C-C) = 0.002 Å; R factor = 0.039; wR factor = 0.108; data-to-parameter ratio = 17.6. organic compounds o1280 Idemudia et al.
The title compound, C 23 H 20 N 4 O, is a heterocyclic phenylhydrazone Schiff base with a pyrazole moiety. In the crystal, a variety of interactions occur, including N-HÁ Á Á andstacking between the phenyl ring of the phenylhydrazinyl group and its symmetry-generated equivalent [centroidcentroid distance = 3.6512 (7) Å ].
Related literature
For related structures, see: Zhu et al. (2010 Zhu et al. ( , 2011 ; Goh et al. (2009) . For general background to pyrazolones and their applications, see: Yang et al. (2000) ; Konstantinovic et al. (2008) ; Joshi et al. (2011); Turan-Zitouni et al. (2000) . For the biological activities of hydrazone Schiff bases, see: Yadav et al. (2010) ; Ozdemir et al. (2008) ; Vicini et al. (2006) ; Jagadeesh et al. (2010) ; Walcourt et al. (2004) and for their catalytic abilities, see: Pouralimardan et al. (2007) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Cg2 is the centroid of the C11-C16 ring. (17) 3.5021 (12) 146.6 (14)
Symmetry code: (i) Àx þ 1; Ày; Àz þ 1.
Data collection: APEX2 (Bruker, 2010) ; cell refinement: SAINT (Bruker, 2010) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) and ShelXle (Hü bschle et al., 2011); molecular graphics: ORTEP-3 (Farrugia,1997) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: PLATON (Spek, 2009) and publCIF (Westrip, 2010) . applications. Antimicrobial (Yadav et al., 2010; Ozdemir et al., 2008) , antitumour (Vicini et al., 2006) , antioxidant (Jagadeesh et al., 2010) , antimalarial (Walcourt et al., 2004) and catalytic (Pouralimardan et al., 2007) activities, amidst others. Heterocyclic Schiff bases derived from pyrazolone have been well documented (Yang et al., 2000) . A new heterocyclic phenylhydrazone Schiff base with pyrazolyl moeity is prepared and its crystal structure reported herein ( Fig.1 ).
In the crystal structure π stacking occurs between the phenyls of adjacent phenylhydazone groups with a centroid to centroid distance of 3.6512 (7) Å and slippage of 0.922 Å (Fig. 2) . The dihedral angles formed by the least square planes between the phenyl of the phenylhydrazone group with the pyrazole and the C21-C26 aromatic ring are 85.29 (6) The packing of the title compound is shown in Figure 3 .
A mixture of phenylhydrazine and 4-benzoyl-3-methyl-1-phenyl-2-pyrazoline-5-one (ratio 1:1) in methanol was refluxed for 5 h. The mixture was poured into cold distilled water to precipitate the yellow titled compound (yield: 92%; m.p: 190-192°C), which was isolated by filtration and recrystalized from methanol. Single crystals of the titled compound suitable for X-ray diffraction was obtained from methanol by slow evaporation at room temperature.
Refinement
The carbon-bound H atoms were placed in calculated positions (C-H 0.95 Å for aromatic carbon atoms and C-H 0.98 Å for the methyl group) and were included in the refinement in the riding model approximation, with U(H) set to 1.2U~eq~(C). The H atoms of the methyl group were allowed to rotate with a fixed angle around the C-C bond to best fit the experimental electron density (HFIX 137 in the SHELX program suite (Sheldrick, 2008) , with U(H) set to 1.5 U~eq~(C)). The nitrogen-bound H atoms were located on a difference Fourier map and refined freely with isotropic parameters.
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Computing details
Data collection: APEX2 (Bruker, 2010) ; cell refinement: SAINT (Bruker, 2010) ; data reduction: SAINT (Bruker, 2010) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) and ShelXle (Hübschle et al., 2011) ; molecular graphics: ORTEP-3 (Farrugia,1997) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: PLATON (Spek, 2009 ) and publCIF (Westrip, 2010) .
Figure 1
The molecular structure of the title compound, with atom labels and anistropic displacement ellipsoids (drawn at 50% probability level).
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Figure 2
Inter and intra molecular contacts as well as the short ring interaction between C31-C36 and C31 i -C36 i (blue dashed line). Symmetry operators: i -x + 1, -y, -z + 2.
Figure 3
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3-Methyl-1-phenyl-4-[(phenyl)(2-phenylhydrazin-1-yl)methylidene]-1H-pyrazol-5(4H)-one
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